Clostridial neurotoxins

Journal of Toxicology - Toxin Reviews

Volumn 21, Issue 3, 2002, Pages 203-227

  Verastegui, C ^a   Lalli, G ^a   Bohnert, S ^a   Meunier, F A ^a   Schiavo, G ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CLOSTRIDIUM TOXIN; METALLOPROTEINASE; NEUROTOXIN; SNARE PROTEIN; TETANUS TOXIN;

BINDING AFFINITY; ENZYME ACTIVITY; EXOCYTOSIS; MEMBRANE PERMEABILITY; MOTONEURON; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; TOXIN ANALYSIS;

CLOSTRIDIUM; POSIBACTERIA;

EID: 0036397838     PISSN: 07313837     EISSN: None     Source Type: Journal    
DOI: 10.1081/TXR-120014404     Document Type: Review

References (129)

1. Habermann, E.; Dreyer, F. Clostridial neurotoxins: Handling and action at the cellular and molecular level. Curr. Top. Microbiol. Immunol. 1986, 129, 93.
2. Schiavo, G.; Matteoli, M.; Montecucco, C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80, 717.
3. Humeau, Y.; Doussau, F.; Grant, N.J.; Poulain, B. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 2000, 82, 427.
4. Meunier, F.A.; Herreros, J.; Schiavo, G.; Poulain, B.; Molgó, J. Handbook of Neurotoxicology; Massaro, E.J., Ed.; Humana Press, Inc.: Totowa, NJ, 2001; 305.
5. Rossetto, O.; Seveso, M.; Caccin, P.; Schiavo, G.; Montecucco, C. Tetanus and botulinum neurotoxins: Turning bad guys into good by research. Toxicon 2001, 39, 27.
6. Lacy, D.B.; Tepp, W.; Cohen, A.C.; DasGupta, B.R.; Stevens, R.C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 1998, 5, 898.
7. Hanson, M.A.; Stevens, R.C. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution. Nat. Struct. Biol. 2000, 7, 687.
8. Swaminathan, S.; Eswaramoorthy, S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 2000, 7, 693.
9. Lacy, D.B.; Stevens, R.C. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 1999, 291, 1091.
10. Johnson, E.A. Clostridial toxins as therapeutic agents: Benefits of nature's most toxic proteins. Annu. Rev. Microbiol. 1999, 53, 551.
11. Popoff, M.R.; Marvaud, J.-C. Bacterial Toxins: A Comprensive Sourcebook; Alouf, J., Freer, J., Eds.; Academic Press: London, 1999; 174.
12. McCroskey, L.M.; Hatheway, C.L.; Fenicia, L.; Pasolini, B.; Aureli, P. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J. Clin. Microbiol. 1986, 23, 201.
13. Wang, X.; Maegawa, T.; Karasawa, T.; Kozaki, S.; Tsukamoto, K.; Gyobu, Y.; Yamakawa, K.; Oguma, K.; Sakaguchi, Y.; Nakamura, S. Genetic analysis of type E botulinum toxin-producing Clostridium butyricum strains. Appl. Environ. Microbiol. 2000, 66, 4992.
14. Hall, J.D.; McCroskey, L.M.; Pincomb, B.J.; Hatheway, C.L. Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism. J. Clin. Microbiol. 1985, 21, 654.
15. Popoff, M.R. Ecology of neurotoxigenic strains of clostridia. Curr. Top. Microbiol. Immunol. 1995, 195, 1.
16. Schiavo, G.; Papini, E.; Genna, G.; Montecucco, C. An intact interchain disulfide bond is required for the neurotoxicity of tetanus toxin. Infect. Immun. 1990, 58, 4136.
17. de Paiva, A.; Poulain, B.; Lawrence, G.W.; Shone, C.C.; Tauc, L.; Dolly, J.O. A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly. J. Biol. Chem. 1993, 268, 20838.
18. Cai, S.; Singh, B.R. Role of the disulfide cleavage induced molten globule state of type a botulinum neurotoxin in its endopeptidase activity. Biochemistry 2001, 40, 15327.
19. Minton, N.P. Molecular genetics of clostridial neurotoxins. Curr. Top. Microbiol. Immunol. 1995, 195, 161.
20. Lalli, G.; Herreros, J.; Osborne, S.L.; Montecucco, C.; Rossetto, O.; Schiavo, G. Functional characterisation of tetanus and botulinum neurotoxins binding domains. J. Cell Sci. 1999, 112, 2715.
21. Inoue, K.; Fujinaga, Y.; Watanabe, T.; Ohyama, T.; Takeshi, K.; Moriishi, K.; Nakajima, H.; Oguma, K. Molecular composition of Clostridium botulinum type A progenitor toxins. Infect. Immun. 1996, 64, 1589.
22. Kitamura, M. Identification of RNA species in the RNA-Toxin complex and structure of the complex in Clostridium botulinum type E. Biochem. Biophys. Res. Commun. 2002, 291, 154.
23. Maksymowych, A.B.; Simpson, L.L. Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells. J. Biol. Chem. 1998, 273, 21950.
24. Herreros, J.; Lalli, G.; Montecucco, C.; Schiavo, G. The Comprehensive Sourcebook of Bacterial Protein Toxins; Freer, J.H., Alouf, J.E., Eds.; Academic Press: London, 1999; 202.
25. Montecucco, C.; Papini, E.; Schiavo, G. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett. 1994, 346, 92.
26. Jahn, R.; Südhof, T.C. Membrane fusion and exocytosis. Annu. Rev. Biochem. 1999, 68, 863.
27. Umland, T.C.; Wingert, L.M.; Swaminathan, S.; Furey, W.F.; Schmidt, J.J.; Sax, M. Structure of the receptor binding fragment HC of tetanus neurotoxin. Nat. Struct. Biol. 1997, 4, 788.
28. Emsley, P.; Fotinou, C.; Black, I.; Fairweather, N.F.; Charles, I.G.; Watts, C.; Hewitt, E.; Isaacs, N.W. The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J. Biol. Chem. 2000, 275, 8889.
29. Fotinou, C.; Emsley, P.; Black, I.; Ando, H.; Ishida, H.; Kiso, M.; Sinha, K.A.; Fairweather, N.F.; Isaacs, N.W. The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin. J. Biol. Chem. 2001, 276, 32274.
30. Simpson, L.L. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu. Rev. Pharmacol. Toxicol. 1986, 26, 427.
31. Halpern, J.L.; Neale, E.A. Neurospecific binding, internalization, and retrograde axonal transport. Curr. Top. Microbiol. Immunol. 1995, 195, 221.
32. Herreros, J.; Lalli, G.; Schiavo, G. C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor. Biochem. J. 2000, 347, 199.
33. Weller, U.; Taylor, C.F.; Habermann, E. Quantitative comparison between tetanus toxin, some fragments and toxoid for binding and axonal transport in the rat. Toxicon 1986, 24, 1055.
34. Francis, J.W.; Hosler, B.A.; Brown, R.H., Jr.; Fishman, P.S. CuZn superoxide dismutase (SOD-1):tetanus toxin fragment C hybrid protein for targeted delivery of SOD-1 to neuronal cells. J. Biol. Chem. 1995, 270, 15434.
35. Li, Y.; Foran, P.; Lawrence, G.; Mohammed, N.; Chan-Kwo-Chion, C.K.; Lisk, G.; Aoki, R.; Dolly, O. Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways. J. Biol. Chem. 2001, 276, 31394.
36. Niemann, H. A Sourcebook of Bacterial Protein Toxins; Alouf, J.E., Freer, J.H., Eds.; Academic Press: London, 1991; 303.
37. Shapiro, R.E.; Specht, C.D.; Collins, B.E.; Woods, A.S.; Cotter, R.J.; Schnaar, R.L. Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand. J. Biol. Chem. 1997, 272, 30380.
38. Sinha, K.; Box, M.; Lalli, G.; Schiavo, G.; Schneider, H.; Groves, M.; Siligardi, G.; Fairweather, N. Analysis of mutants of tetanus toxin Hc fragment: Ganglioside binding, cell binding and retrograde axonal transport properties. Mol. Microbiol. 2000, 37, 1041.
39. Ginalski, K.; Venclovas, C.; Lesyng, B.; Fidelis, K. Structure-based sequence alignment for the beta-trefoil subdomain of the clostridial neurotoxin family provides residue level information about the putative ganglioside binding site. FEBS Lett. 2000, 482, 119.
40. Sutton, J.M.; Chow-Worn, O.; Spaven, L.; Silman, N.J.; Hallis, B.; Shone, C.C. Tyrosine-1290 of tetanus neurotoxin plays a key role in its binding to gangliosides and functional binding to neurones. FEBS Lett. 2001, 493, 45.
41. Montecucco, C.; Papini, E.; Schiavo, G. A Sourcebook of Bacterial Protein Toxins; Alouf, J.E., Freer, J.H., Eds.; Academic Press: London, 1991; 45.
42. Hefferos, J.; Schiavo, G. Lipid microdomains are involved in neurospecific binding and internalisation of clostridial neurotoxins. Int. J. Med. Microbiol. 2002, 291, 447.
43. Nishiki, T.; Kamata, Y.; Nemoto, Y.; Omori, A.; Ito, T.; Takahashi, M.; Kozaki, S. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 1994, 269, 10498.
44. Li, L.; Singh, B.R. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay. J. Nat. Toxins 1998, 7, 215.
45. Nishiki, T.; Tokuyama, Y.; Kamata, Y.; Nemoto, Y.; Yoshida, A.; Sato, K.; Sekiguchi, M.; Takahashi, M.; Kozaki, S. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett. 1996, 378, 253.
46. Bakry, N.M.; Kamata, Y.; Simpson, L.L. Expression of botulinum toxin binding sites in Xenopus oocytes. Infect. Immun. 1997, 65, 2225.
47. Herreros, J.; Lalli, G.; Montecucco, C.; Schiavo, G. Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons. J. Neurochem. 2000, 74, 1941.
48. Herreros, J.; Ng, T.; Schiavo, G. Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. Mol. Biol. Cell 2001, 12, 2947.
49. Harder, T.; Scheiffele, P.; Verkade, P.; Simons, K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 1998, 141, 929.
50. Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1, 31.
51. Munro, P.; Kojima, H.; Dupont, J.L.; Bossu, J.L.; Poulain, B.; Boquet, P. High sensitivity of mouse neuronal cells to tetanus toxin requires a GPI-anchored protein. Biochem. Biophys. Res. Commun. 2001, 289, 623.
52. Fivaz, M.; Abrami, L.; van der Goot, F.G. Pathogens, toxins, and lipid rafts. Protoplasma 2000, 212, 8.
53. Parton, R.G.; Ockleford, C.D.; Critchley, D.R. A study of the mechanism of internalisation of tetanus toxin by primary mouse spinal cord cultures. J. Neurochem. 1987, 49, 1057.
54. NTR. J. Cell Biol. 2002, 156, 233.
55. Goldstein, L.S.; Yang, Z. Microtubule-based transport systems in neurons: The roles of kinesins and dyneins. Annu. Rev. Neurosci. 2000, 23, 39.
56. Stöckel, K.; Schwab, M.; Thoenen, H. Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons. Brain Res. 1975, 99, 1.
57. Matteoli, M.; Verderio, C.; Rossetto, O.; Iezzi, N.; Coco, S.; Schiavo, G.; Montecucco, C. Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 13310.
58. Verderio, C.; Coco, S.; Rossetto, O. Montecucco, C.; Matteoli, M. Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes. J. Neurochem. 1999, 73, 372.
59. Simpson, L.L.; Coffield, J.A.; Bakry, N. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. J. Pharmacol. Exp. Ther. 1994, 269, 256.
60. Williamson, L.C.; Neale, E.A. Bafilomycin A1 inhibits the action of tetanus toxin in spinal cord neurons in cell culture. J. Neurochem. 1994, 63, 2342.
61. Boquet, P.; Duflot, E. Tetanus toxin fragment forms channels in lipid vesicles at low pH. Proc. Natl. Acad. Sci. U. S. A. 1982, 79, 7614.
62. Schmid, M.F.; Robinson, J.P.; DasGupta, B.R. Direct visualization of botulinum neurotoxin-induced channels in phospholipid vesicles. Nature 1993, 364, 827.
63. Beise, J.; Hahnen, J.; Andersen-Beckh, B.; Dreyer, F. Pore formation by tetanus toxin, its chain and fragments in neuronal membranes and evaluation of the underlying motifs in the structure of the toxin molecule. Naunyn Schmiedebergs Arch. Pharmacol. 1994, 349, 66.
64. Sheridan, R.E. Gating and permeability of ion channels produced by botulinum toxin types A and E in PC12 cell membranes. Toxicon 1998, 36, 703.
65. Cabiaux, V.; Lorge, P.; Vandenbranden, M.; Falmagne, P.; Ruysschaert, J.M. Tetanus toxin induces fusion and aggregation of lipid vesicles containing phosphatidylinositol at low pH. Biochem. Biophys. Res. Commun. 1985, 128, 840.
66. Papini, E.; Sandona, D.; Rappuoli, R.; Montecucco, C. On the membrane translocation of diphtheria toxin: At low pH the toxin induces ion channels on cells. EMBO J. 1988, 7, 3353.
67. van der Goot, F.G.; Gonzalez-Manas, J.M.; Lakey, J.H.; Pattus, F. A 'molten-globule' membrane-insertion intermediate of the pore-forming domain of colicin A. Nature 1991, 354, 408.
68. Li, L.; Singh, B.R. Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain. Biochemistry 2000, 39, 6466.
69. Jongeneel, C.V.; Bouvier, J.; Bairoch, A. A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett. 1989, 242, 211.
70. Rossetto, O.; Caccin, P.; Rigoni, M.; Tonello, F.; Bortoletto, N.; Stevens, R.C.; Montecucco, C. Active-site mutagenesis of tetanus neurotoxin implicates TYR-375 and GLU-271 in metalloproteolytic activity. Toxicon 2001, 39, 1151.
71. Binz, T.; Bade, S.; Rummel, A.; Kollewe, A.; Alves, J. Arg(362) and tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization. Biochemistry 2002, 41, 1717.
72. Rawlings, N.D.; Barrett, A.J. Evolutionary families of metallopeptidases. Methods Enzymol. 1995, 248, 183.
73. Li, L.; Singh, B.R. Role of zinc binding in type A botulinum neurotoxin light chain's toxic structure. Biochemistry 2000, 39, 10581.
74. De Filippis, V.; Vangelista, L.; Schiavo, G.; Tonello, F.; Montecucco, C. Structural studies on the zinc-endopeptidase light chain of tetanus neurotoxin. Eur. J. Biochem. 1995, 229, 61.
75. Tonello, F.; Schiavo, G.; Montecucco, C. Metal substitution of tetanus neurotoxin. Biochem. J. 1997, 322, 507.
76. Encinar, J.A.; Fernandez, A.; Ferragut, J.A.; Gonzalez-Ros, J.M.; DasGupta, B.R.; Montal, M.; Ferrer-Montiel, A. Structural stabilization of botulinum neurotoxins by tyrosine phosphorylation. FEBS Lett. 1998, 429, 78.
77. Blanes-Mira, C.; Ibanez, C.; Fernandez-Ballester, G.; Planells-Cases, R.; Perez-Paya, E.; Ferrer-Montiel, A. Thermal stabilization of the catalytic domain of botulinum neurotoxin E by phosphorylation of a single tyrosine residue. Biochemistry 2001, 40, 2234.
78. Ferrer-Montiel, A.V.; Canaves, J.M.; DasGupta, B.R.; Wilson, M.C.; Montal, M. Tyrosine phosphorylation modulates the activity of clostridial neurotoxins. J. Biol. Chem. 1996, 271, 18322.
79. Chen, Y.A.; Scheller, R.H. SNARE-mediated membrane fusion. Nat. Rev. Mol. Cell Biol. 2001, 2, 98.
80. Sutton, R.B.; Fasshauer, D.; Jahn, R.; Brunger, A.T. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 1998, 395, 347.
81. Söllner, T.; Whiteheart, S.W.; Brunner, M.; Erdjument-Bromage, H.; Geromanos, S.; Tempst, P.; Rothman, J.E. SNAP receptors implicated in vesicle targeting and fusion. Nature 1993, 362, 318.
82. Weber, T.; Zemelman, B.V.; McNew, J.A.; Westermann, B.; Gmachl, M.; Parlati, F.; Sollner, T.H.; Rothman, J.E. SNAREpins: Minimal machinery for membrane fusion. Cell 1998, 92, 759.
83. McNew, J.A.; Parlati, F.; Fukuda, R.; Johnston, R.J.; Paz, K.; Paumet, F.; Sollner, T.H.; Rothman, J.E. Compartmental specificity of cellular membrane fusion encoded in SNARE proteins. Nature 2000, 407, 153.
84. Schiavo, G.; Benfenati, F.; Poulain, B.; Rossetto, O.; Polverino de Laureto, P.; DasGupta, B.R.; Montecucco, C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992, 359, 832.
85. Rossetto, O.; Schiavo, G.; Montecucco, C.; Poulain, B.; Deloye, F.; Lozzi, L.; Shone, C.C. SNARE motif and neurotoxins. Nature 1994, 372, 415.
86. Pellizzari, R.; Rossetto, O.; Lozzi, L.; Giovedi, S.; Johnson, E.; Shone, C.C.; Montecucco, C. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins. J. Biol. Chem. 1996, 271, 20353.
87. Pellizzari, R.; Mason, S.; Shone, C.C.; Montecucco, C. The interaction of synaptic vesicle-associated membrane protein/synaptobrevin with botulinum neurotoxins D and F. FEBS Lett. 1997, 409, 339.
88. Washbourne, P.; Pellizzari, R.; Baldini, G.; Wilson, M.C.; Montecucco, C. Botulinum neurotoxin type-A and type-E require the SNARE motif in SNAP-25 for proteolysis. FEBS Lett. 1997, 418, 1.
89. Hunt, J.M.; Bommert, K.; Charlton, M.P.; Kistner, A.; Habermann, E.; Augustine, G.J.; Betz, H. A post-docking role for synaptobrevin in synaptic vesicle fusion. Neuron 1994, 12, 1269.
90. Osen-Sand, A.; Staple, J.K.; Naldi, E.; Schiavo, G.; Rossetto, O.; Petitpierre, S.; Malgaroli, A.; Montecucco, C.; Catsicas, S. Common and distinct fusion proteins in axonal growth and transmitter release. J. Comp. Neurol. 1996, 367, 222.
91. Neale, E.A.; Bowers, L.M.; Jia, M.; Bateman, K.E.; Williamson, L.C. Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal. J. Cell Biol. 1999, 147, 1249.
92. Hayashi, T.; McMahon, H.; Yamasaki, S.; Binz, T.; Hata, Y.; Sudhof, T.C.; Niemann, H. Synaptic vesicle membrane fusion complex: Action of clostridial neurotoxins on assembly. EMBO J. 1994, 13, 5051.
93. Chapman, E.R.; An, S.; Barton, N.; Jahn, R. SNAP-25, a t-SNARE which binds to both syntaxin and synaptobrevin via domains that may form coiled coils. J. Biol. Chem. 1994, 269, 27427.
94. Pellegrini, L.L.; O'Connor, V.; Lottspeich, F.; Betz, H. Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion. EMBO J. 1995, 14, 4705.
95. Chen, Y.A.; Scales, S.J.; Scheller, R.H. Sequential SNARE assembly underlies priming and triggering of exocytosis. Neuron 2001, 30, 161.
96. Keller, J.E.; Neale, E.A. The role of the synaptic protein SNAP-25 in the potency of botulinum neurotoxin type A. J. Biol. Chem. 2001, 276, 13476.
97. Eisel, U.; Reynolds, K.; Riddick, M.; Zimmer, A.; Niemann, H.; Zimmer, A. Tetanus toxin light chain expression in Sertoli cells of transgenic mice causes alterations of the actin cytoskeleton and disrupts spermatogenesis. EMBO J. 1993, 12, 3365.
98. Sweeney, S.T.; Broadie, K.; Keane, J.; Niemann, H.; O'Kane, C.J. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron 1995, 14, 341.
99. 2+-dependent exocytosis. J. Biol. Chem. 1996, 271, 20227.
100. Lang, J.; Regazzi, R.; Wollheim, C.B. Bacterial Toxins. Tools in Cell Biology and Pharmacology; Aktories, K., Ed.; Chapman & Hall: London, 1997; 217.
101. Xu, T.; Binz, T.; Niemann, H.; Neher, E. Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity. Nat. Neurosci. 1998, 1, 192.
102. O'Sullivan, G.A.; Mohammed, N.; Foran, P.G.; Lawrence, G.W.; Dolly, J.O. Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues. J. Biol. Chem. 1999, 274, 36897.
103. Gerona, R.R.; Larsen, E.C.; Kowalchyk, J.A.; Martin, T.F. The C terminus of SNAP25 is essential for Ca(2+)-dependent binding of synaptotagmin to SNARE complexes. J. Biol. Chem. 2000, 275, 6328.
104. Keller, A.; Sweeney, S.T.; Zars, T.; O'Kane, C.J.; Heisenberg, M. Targeted expression of tetanus neurotoxin interferes with behavioral responses to sensory input in Drosophila. J. Neurobiol. 2002, 50, 221.
105. Raciborska, D.A.; Trimble, W.S.; Charlton, M.P. Presynaptic protein interactions in vivo: Evidence from botulinum A, C, D and E action at frog neuromuscular junction. Eur. J. Neurosci. 1998, 10, 2617.
106. Raciborska, D.A.; Charlton, M.P. Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: A new hypothesis to explain persistence of botulinum A poisoning. Can. J. Physiol. Pharmacol. 1999, 77, 679.
107. de Paiva, A.; Meunier, F.A.; Molgo, J.; Aoki, K.R.; Dolly, J.O. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 3200.
108. Jankovic, J.; Hallett, M. Therapy with Botulinum Toxin; Marcel Dekker: New York, 1994.
109. Brashear, A. Botulinum toxin type B: A new injectable treatment for cervical dystonia. Expert. Opin. Investig. Drugs 2001, 10, 2191.
110. Eleopra, R.; Tugnoli, V.; Rossetto, O.; Montecucco, C.; De Grandis, D. Botulinum neurotoxin serotype C: A novel effective botulinum toxin therapy in human. Neurosci. Lett. 1997, 224, 91.
111. Chen, R.; Karp, B.I.; Hallett, M. Botulinum toxin type F for treatment of dystonia: Long-term experience. Neurology 1998, 51, 1494.
112. Montecucco, C.; Schiavo, G.; Tugnoli, V.; de Grandis, D. Botulinum neurotoxins: Mechanism of action and therapeutic applications. Mol. Med. Today 1996, 2, 418.
113. Carruthers, A.; Carruthers, J. Botulinum toxin type A: History and current cosmetic use in the upper face. Semin. Cutan. Med. Surg. 2001, 20, 71.
114. Verheyden, J.; Blitzer, A.; Brin, M.F. Other noncosmetic uses of BOTOX. Semin. Cutan. Med. Surg. 2001, 20, 121.
115. Filippi, G.M.; Errico, P.; Santarelli, R.; Bagolini, B.; Manni, E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 1993, 113, 400.
116. Rosales, R.L.; Arimura, K.; Takenaga, S.; Osame, M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection. Muscle Nerve 1996, 19, 488.
117. Wollina, U.; Karamfilov, T.; Konrad, H. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J. Am. Acad. Dermatol. 2002, 46, 536.
118. Ellies, M.; Laskawi, R.; Rohrbach-Volland, S.; Arglebe, C.; Beuche, W. Botulinum toxin to reduce saliva flow: Selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope 2002, 112, 82.
119. Ishikawa, H.; Mitsui, Y.; Yoshitomi, T.; Mashimo, K.; Aoki, S.; Mukuno, K.; Shimizu, K. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn. J. Ophthalmol. 2000, 44, 106.
120. Welch, M.J.; Purkiss, J.R.; Foster, K.A. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000, 38, 245.
121. Gui, D.; De Gaetano, A.; Spada, P.L.; Viggiano, A.; Cassetta, E.; Albanese, A. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Aliment. Pharmacol. Ther. 2000, 14, 829.
122. Finnerty, G.T.; Jefferys, J.G. 9-16 Hz oscillation precedes secondary generalization of seizures in the rat tetanus toxin model of epilepsy. J. Neurophysiol. 2000, 83, 2217.
123. Lee, C.L.; Hannay, J.; Hrachovy, R.; Rashid, S.; Antalffy, B.; Swann, J.W. Spatial learning deficits without hippocampal neuronal loss in a model of early-onset epilepsy. Neuroscience 2001, 107, 71.
124. Bagetta, G.; Nistico, G. Tetanus toxin as a neurobiological tool to study mechanisms of neuronal cell death in the mammalian brain. Pharmacol. Ther. 1994, 62, 29.
125. Dobrenis, K.; Joseph, A.; Rattazzi, M.C. Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 2297.
126. Figueiredo, D.M.; Hallewell, R.A.; Chen, L.L.; Fairweather, N.F.; Dougan, G.; Savitt, J.M.; Parks, D.A.; Fishman, P.S. Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous system neurons by retrograde axonal transport. Exp. Neurol. 1997, 145, 546.
127. Miana-Mena, F.J.; Roux, S.; Benichou, J.C.; Osta, R.; Brulet, P. Neuronal activity-dependent membrane traffic at the neuromuscular junction. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 3234.
128. Coen, L.; Osta, R.; Maury, M.; Brulet, P. Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 9400.
129. Goodnough, M.C.; Oyler, G.; Fishman, P.S.; Johnson, E.A.; Neale, E.A.; Keller, J.E.; Tepp, W.H.; Clark, M.; Hartz, S.; Adler, M. Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonists. FEBS Lett. 2002, 513, 163.